|
Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights
|
Dec 2013
|
Hematology Am Soc Hematol Educ Program
|
myelodysplastic syndromes (MDS)
|
|
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC)
|
Nov 2013
|
Pediatr Blood Cancer
|
aplastic anemia
|
|
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Reduced intensity conditioning and co-transplantation of unrelated peripheral stem cells combined with umbilical cord mesenchymal stem/stroma cells for young patients with refractory severe aplastic anemia.
|
Nov 2013
|
Int J Hematol
|
aplastic anemia
|
|
Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes
|
Nov 2013
|
Sci Rep
|
myelodysplastic syndromes (MDS)
|
|
Transplantation for myelodysplastic syndromes 2013.
|
Nov 2013
|
Curr Opin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Epigenetics of myelodysplastic syndromes
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry
|
Nov 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.
|
Nov 2013
|
Cytometry B Clin Cytom
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition
|
Nov 2013
|
Expert Rev Clin Immunol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
